This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Cefazolin for Injection (2017-06-03)
- Starting date:
- June 3, 2017
- Posting date:
- June 5, 2017
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-63494
Reason
Affected lot may contain presence of foreign matter.
Depth of distribution
Wholesalers, hospitals, pharmacies in the following provinces: ON, BC, NS, QC, AB, NB
Affected products
Cefazolin for Injection
DIN, NPN, DIN-HIM
DIN 02237140
Dosage form
Powder for solution
Strength
Cefazolin Sodium 10 g/vial
Lot or serial number
303723
Companies
- Recalling Firm
-
FRESENIUS KABI CANADA LTD
165 Galaxy Blvd, Suite 100
Toronto
M9W 0C8
Ontario
CANADA
- Marketing Authorization Holder
-
FRESENIUS KABI CANADA LTD
165 Galaxy Blvd, Suite 100
Toronto
M9W 0C8
Ontario
CANADA